IOL CHEMICALS & PHARM. | VAISHALI PHARMA | IOL CHEMICALS & PHARM./ VAISHALI PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 29.4 | 45.1% | View Chart |
P/BV | x | 1.5 | 5.2 | 29.0% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. VAISHALI PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
VAISHALI PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ VAISHALI PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 194 | 277.0% | |
Low | Rs | 272 | 64 | 423.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 66.0 | 571.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | 6.3 | 378.6% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 6.7 | 468.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 31.3 | 821.7% | |
Shares outstanding (eoy) | m | 58.71 | 10.55 | 556.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.0 | 54.8% | |
Avg P/E ratio | x | 17.1 | 20.6 | 82.8% | |
P/CF ratio (eoy) | x | 12.8 | 19.1 | 66.9% | |
Price / Book Value ratio | x | 1.6 | 4.1 | 38.2% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 1,361 | 1,744.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 13 | 12,929.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 697 | 3,182.6% | |
Other income | Rs m | 256 | 22 | 1,148.9% | |
Total revenues | Rs m | 22,427 | 719 | 3,119.6% | |
Gross profit | Rs m | 2,257 | 94 | 2,406.4% | |
Depreciation | Rs m | 462 | 5 | 9,158.7% | |
Interest | Rs m | 165 | 23 | 730.1% | |
Profit before tax | Rs m | 1,887 | 88 | 2,132.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 22 | 2,207.3% | |
Profit after tax | Rs m | 1,391 | 66 | 2,106.9% | |
Gross profit margin | % | 10.2 | 13.5 | 75.6% | |
Effective tax rate | % | 26.2 | 25.4 | 103.5% | |
Net profit margin | % | 6.3 | 9.5 | 66.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 727 | 1,330.2% | |
Current liabilities | Rs m | 5,025 | 321 | 1,567.0% | |
Net working cap to sales | % | 20.9 | 58.3 | 35.9% | |
Current ratio | x | 1.9 | 2.3 | 84.9% | |
Inventory Days | Days | 43 | 18 | 240.8% | |
Debtors Days | Days | 8 | 2,809 | 0.3% | |
Net fixed assets | Rs m | 11,017 | 61 | 18,111.8% | |
Share capital | Rs m | 587 | 105 | 556.7% | |
"Free" reserves | Rs m | 14,490 | 224 | 6,461.6% | |
Net worth | Rs m | 15,077 | 330 | 4,572.7% | |
Long term debt | Rs m | 0 | 52 | 0.0% | |
Total assets | Rs m | 20,684 | 788 | 2,626.4% | |
Interest coverage | x | 12.5 | 4.9 | 253.1% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.9 | 121.2% | |
Return on assets | % | 7.5 | 11.2 | 66.9% | |
Return on equity | % | 9.2 | 20.0 | 46.1% | |
Return on capital | % | 13.6 | 29.1 | 46.8% | |
Exports to sales | % | 26.7 | 25.2 | 106.2% | |
Imports to sales | % | 0 | 7.8 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 176 | 3,378.4% | |
Imports (cif) | Rs m | NA | 54 | 0.0% | |
Fx inflow | Rs m | 5,930 | 176 | 3,378.4% | |
Fx outflow | Rs m | 6,052 | 55 | 11,001.3% | |
Net fx | Rs m | -122 | 121 | -101.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 11 | 11,321.3% | |
From Investments | Rs m | -1,200 | 3 | -42,553.2% | |
From Financial Activity | Rs m | -41 | -17 | 237.3% | |
Net Cashflow | Rs m | -18 | -4 | 496.0% |
Indian Promoters | % | 48.2 | 26.6 | 181.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 73.4 | 70.6% | |
Shareholders | 130,003 | 9,181 | 1,416.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | VAISHALI PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.57% | -2.32% | -0.43% |
1-Month | -3.91% | 5.40% | 2.16% |
1-Year | -3.49% | 13.15% | 49.83% |
3-Year CAGR | -11.82% | 65.26% | 14.21% |
5-Year CAGR | 15.50% | 47.64% | 19.20% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the VAISHALI PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of VAISHALI PHARMA the stake stands at 26.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of VAISHALI PHARMA .
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
VAISHALI PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of VAISHALI PHARMA .
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.